Tissue specific determinants of glucocorticoid signalling in humans - new mechanisms and therapies for cardiovascular risk. (Renewal: YYRS 11-15)

Walker, Brian (Principal Investigator)

Status	Finished
Effective start/end date	1/04/11 → 31/03/16

Funding

UK-based charities: £1,146,240.00

9 Article

Non-invasive in vivo assessment of 11β-hydroxysteroid dehydrogenase type 1 activity by 19 F-magnetic resonance spectroscopy
Naredo-Gonzalez, G., Upreti, R., Jansen, M. A., Semple, S., Sutcliffe, O. B., Marshall, I., Walker, B. R. & Andrew, R., 29 Sept 2022, In: Scientific Reports.
Research output: Contribution to journal › Article › peer-review

Open Access
File
ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans
Kyle, C. J., Nixon, M., Homer, N. Z. M., Morgan, R. A., Andrew, R., Stimson, R. H. & Walker, B. R., 1 Mar 2022, In: Metabolism. 128, 155118.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia
Alwashih, M. A., Watson, D. G., Andrew, R., Stimson, R. H., Alossaimi, M., Blackburn, G. & Walker, B. R., 6 Dec 2017, In: Scientific Reports. 7, 1, p. 17092
Research output: Contribution to journal › Article › peer-review

Open Access
File